Literature DB >> 7681597

Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128).

H Nakada1, M Inoue, Y Numata, N Tanaka, I Funakoshi, S Fukui, A Mellors, I Yamashina.   

Abstract

Glycophorin A was digested with glycoprotease (Pasteurella haemolytica) and the digest was fractionated by a combination of high-pressure column chromatographies to produce the glycopeptides GPA-1 to GPA-6. Sequence analysis of the glycopeptides revealed that two serine residues (Ser-14 and Ser-15) are not glycosylated, Thr-17 and Ser-19 being glycosylated instead, in disagreement with the accepted structure. The glycopeptides thus obtained were treated with sialidase and beta-galactosidase. The Tn antigenicity, as assayed by the binding to a monoclonal anti-Tn antibody (MLS 128), was found exclusively in the glycopeptides including three (cluster I) or four (cluster II) consecutive residues of GalNAc-Ser/Thr, whereas the glycopeptide (GPA-2) containing two nonconsecutive GalNAc-Ser/Thr residues had practically no Tn antigenicity. The immunoreactivities of GPA-1 and GPA-3, containing both clusters I and II, and GPA-4, containing cluster II, were 63% (calcd. 67%), 81% (calcd. 86%), and 50% (calcd. 50%), respectively, of the immunoreactivity of GPA-5 or GPA-6, containing cluster I (the average being taken as the basis), based on the reactivity per GalNAc residue. These results indicate that clusters I and II react with the antibody to the same extent. The structure consisting of three consecutive glycosylated Ser/Thr residues may be essential for Tn antigenicity in the light of previous results for ovine submaxillary mucin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681597      PMCID: PMC46114          DOI: 10.1073/pnas.90.6.2495

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Acquired hemolytic anemia with polyagglutinability of red blood cells due to a new factor present in normal human serum (Anti-Tn).

Authors:  J DAUSSET; J MOULLEC; J BERNARD
Journal:  Blood       Date:  1959-10       Impact factor: 22.113

2.  A neutral glycoprotease of Pasteurella haemolytica A1 specifically cleaves O-sialoglycoproteins.

Authors:  K M Abdullah; E A Udoh; P E Shewen; A Mellors
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Cryptic A-like receptor sites in human erythrocyte glycoproteins: proposed nature of Tn-antigen.

Authors:  W Dahr; G Uhlenbruck; G W Bird
Journal:  Vox Sang       Date:  1974       Impact factor: 2.144

4.  Structural studies on human erythrocyte glycoproteins. Alkali-labile oligosaccharides.

Authors:  D B Thomas; R J Winzler
Journal:  J Biol Chem       Date:  1969-11-10       Impact factor: 5.157

5.  A monoclonal antibody directed to Tn antigen.

Authors:  Y Numata; H Nakada; S Fukui; H Kitagawa; K Ozaki; M Inoue; T Kawasaki; I Funakoshi; I Yamashina
Journal:  Biochem Biophys Res Commun       Date:  1990-08-16       Impact factor: 3.575

6.  Expression of the Tn antigen on T-lymphoid cell line Jurkat.

Authors:  H Nakada; M Inoue; N Tanaka; Y Numata; H Kitagawa; S Fukui; I Yamashina
Journal:  Biochem Biophys Res Commun       Date:  1991-09-16       Impact factor: 3.575

7.  Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus.

Authors:  J E Hansen; C Nielsen; M Arendrup; S Olofsson; L Mathiesen; J O Nielsen; H Clausen
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Biosynthesis of truncated O-glycans in the T cell line Jurkat. Localization of O-glycan initiation.

Authors:  V Piller; F Piller; M Fukuda
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

9.  Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16.

Authors:  A Pallant; A Eskenazi; M G Mattei; R E Fournier; S R Carlsson; M Fukuda; J G Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

10.  Amino-acid sequence and oligosaccharide attachment sites of human erythrocyte glycophorin.

Authors:  M Tomita; V T Marchesi
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

View more
  18 in total

1.  Probing cell-surface architecture through synthesis: an NMR-determined structural motif for tumor-associated mucins.

Authors:  D H Live; L J Williams; S D Kuduk; J B Schwarz; P W Glunz; X T Chen; D Sames; R A Kumar; S J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.

Authors:  Ola Blixt; Olga I Lavrova; Dmitriy V Mazurov; Emiliano Cló; Stjepan K Kracun; Nicolai V Bovin; Alexander V Filatov
Journal:  Glycobiology       Date:  2011-12-05       Impact factor: 4.313

3.  Specificity studies of an antibody developed against a mucin-type glycoprotein.

Authors:  S Haavik; M Nilsen; T Thingstad; H Barsett; D V Renouf; E F Hounsell; J F Codington
Journal:  Glycoconj J       Date:  1999-03       Impact factor: 2.916

4.  Antibody recognition of a unique tumor-specific glycopeptide antigen.

Authors:  Cory L Brooks; Andrea Schietinger; Svetlana N Borisova; Peter Kufer; Mark Okon; Tomoko Hirama; C Roger Mackenzie; Lai-Xi Wang; Hans Schreiber; Stephen V Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

5.  Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice.

Authors:  V Kudryashov; P W Glunz; L J Williams; S Hintermann; S J Danishefsky; K O Lloyd
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  Distribution of Tn antigen recognized by an anti-Tn monoclonal antibody (MLS128) in normal and malignant tissues of the digestive tract.

Authors:  G Ohshio; T Imamura; M Imamura; H Yamabe; H Sakahara; H Nakada; I Yamashina
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen.

Authors:  Christine Sedlik; Adèle Heitzmann; Sophie Viel; Rafik Ait Sarkouh; Cornélie Batisse; Frédéric Schmidt; Philippe De La Rochere; Nathalie Amzallag; Eduardo Osinaga; Pablo Oppezzo; Otto Pritsch; Xavier Sastre-Garau; Pascale Hubert; Sebastian Amigorena; Eliane Piaggio
Journal:  Oncoimmunology       Date:  2016-04-22       Impact factor: 8.110

8.  Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients.

Authors:  S Adluri; F Helling; S Ogata; S Zhang; S H Itzkowitz; K O Lloyd; P O Livingston
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

9.  Coexpression of cancer-associated carbohydrate antigens, Tn and sialyl Tn.

Authors:  H Nakada; M Inoue; N Tanaka; I Yamashina
Journal:  Glycoconj J       Date:  1994-06       Impact factor: 2.916

10.  Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant.

Authors:  E Osinaga; G Pancino; N Porchet; N Berois; P De Cremoux; D Mistro; J P Aubert; F Calvo; A Roseto
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.